223 related articles for article (PubMed ID: 27169995)
1. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS
Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995
[TBL] [Abstract][Full Text] [Related]
2. The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.
Nie H; Huang PQ; Jiang SH; Yang Q; Hu LP; Yang XM; Li J; Wang YH; Li Q; Zhang YF; Zhu L; Zhang YL; Yu Y; Xiao GG; Sun YW; Ji J; Zhang ZG
Theranostics; 2021; 11(8):3898-3915. PubMed ID: 33664869
[TBL] [Abstract][Full Text] [Related]
3. Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer.
Kumar K; Kanojia D; Bentrem DJ; Hwang RF; Butchar JP; Tridandapani S; Munshi HG
Cells; 2023 May; 12(11):. PubMed ID: 37296612
[TBL] [Abstract][Full Text] [Related]
4. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery.
Li X; Truty MA; Kang Y; Chopin-Laly X; Zhang R; Roife D; Chatterjee D; Lin E; Thomas RM; Wang H; Katz MH; Fleming JB
Clin Cancer Res; 2014 Dec; 20(24):6529-40. PubMed ID: 25336691
[TBL] [Abstract][Full Text] [Related]
5. Glycolysis and tumor progression promoted by the m
Yang K; Zhong Z; Zou J; Liao JY; Chen S; Zhou S; Zhao Y; Li J; Yin D; Huang K; Li Y
Cancer Lett; 2024 May; 590():216840. PubMed ID: 38604311
[TBL] [Abstract][Full Text] [Related]
6. Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors.
Roy Chaudhuri T; Lin Q; Stachowiak EK; Rosario SR; Spernyak JA; Ma WW; Stachowiak MK; Greene MK; Quinn GP; McDade SS; Clynes M; Scott CJ; Straubinger RM
Clin Cancer Res; 2024 Apr; 30(7):1367-1381. PubMed ID: 38270582
[TBL] [Abstract][Full Text] [Related]
7. Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma.
Chung KM; Singh J; Lawres L; Dorans KJ; Garcia C; Burkhardt DB; Robbins R; Bhutkar A; Cardone R; Zhao X; Babic A; Vayrynen SA; Dias Costa A; Nowak JA; Chang DT; Dunne RF; Hezel AF; Koong AC; Wilhelm JJ; Bellin MD; Nylander V; Gloyn AL; McCarthy MI; Kibbey RG; Krishnaswamy S; Wolpin BM; Jacks T; Fuchs CS; Muzumdar MD
Cell; 2020 May; 181(4):832-847.e18. PubMed ID: 32304665
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer.
Steele NG; Biffi G; Kemp SB; Zhang Y; Drouillard D; Syu L; Hao Y; Oni TE; Brosnan E; Elyada E; Doshi A; Hansma C; Espinoza C; Abbas A; The S; Irizarry-Negron V; Halbrook CJ; Franks NE; Hoffman MT; Brown K; Carpenter ES; Nwosu ZC; Johnson C; Lima F; Anderson MA; Park Y; Crawford HC; Lyssiotis CA; Frankel TL; Rao A; Bednar F; Dlugosz AA; Preall JB; Tuveson DA; Allen BL; Pasca di Magliano M
Clin Cancer Res; 2021 Apr; 27(7):2023-2037. PubMed ID: 33495315
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells.
Gailhouste L; Liew LC; Hatada I; Nakagama H; Ochiya T
Cell Death Dis; 2018 May; 9(5):468. PubMed ID: 29700299
[TBL] [Abstract][Full Text] [Related]
10. Type I collagen deletion in αSMA
Chen Y; Kim J; Yang S; Wang H; Wu CJ; Sugimoto H; LeBleu VS; Kalluri R
Cancer Cell; 2021 Apr; 39(4):548-565.e6. PubMed ID: 33667385
[TBL] [Abstract][Full Text] [Related]
11. Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer.
Singh SP; Dosch AR; Mehra S; De Castro Silva I; Bianchi A; Garrido VT; Zhou Z; Adams A; Amirian H; Box EW; Sun X; Ban Y; Datta J; Nagathihalli NS; Merchant NB
Cancer Res; 2024 Apr; 84(8):1320-1332. PubMed ID: 38285896
[TBL] [Abstract][Full Text] [Related]
12. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.
Morris JP; Wang SC; Hebrok M
Nat Rev Cancer; 2010 Oct; 10(10):683-95. PubMed ID: 20814421
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting stromal Class I HDACs curbs pancreatic cancer progression.
Liang G; Oh TG; Hah N; Tiriac H; Shi Y; Truitt ML; Antal CE; Atkins AR; Li Y; Fraser C; Ng S; Pinto AFM; Nelson DC; Estepa G; Bashi S; Banayo E; Dai Y; Liddle C; Yu RT; Hunter T; Engle DD; Han H; Von Hoff DD; Downes M; Evans RM
Nat Commun; 2023 Dec; 14(1):7791. PubMed ID: 38057326
[TBL] [Abstract][Full Text] [Related]
14. Drivers of Gene Expression Dysregulation in Pancreatic Cancer.
Venkat S; Alahmari AA; Feigin ME
Trends Cancer; 2021 Jul; 7(7):594-605. PubMed ID: 33618999
[TBL] [Abstract][Full Text] [Related]
15. Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways.
Ho WJ; Erbe R; Danilova L; Phyo Z; Bigelow E; Stein-O'Brien G; Thomas DL; Charmsaz S; Gross N; Woolman S; Cruz K; Munday RM; Zaidi N; Armstrong TD; Sztein MB; Yarchoan M; Thompson ED; Jaffee EM; Fertig EJ
Genome Biol; 2021 May; 22(1):154. PubMed ID: 33985562
[TBL] [Abstract][Full Text] [Related]
16. SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer.
Harris NLE; Vennin C; Conway JRW; Vine KL; Pinese M; Cowley MJ; Shearer RF; Lucas MC; Herrmann D; Allam AH; Pajic M; Morton JP; ; Biankin AV; Ranson M; Timpson P; Saunders DN
Oncogene; 2017 Jul; 36(30):4288-4298. PubMed ID: 28346421
[TBL] [Abstract][Full Text] [Related]
17. Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models.
Nakazawa Y; Miyano M; Tsukamoto S; Kogai H; Yamamoto A; Iso K; Inoue S; Yamane Y; Yabe Y; Umihara H; Taguchi J; Akagi T; Yamaguchi A; Koga M; Toshimitsu K; Hirayama T; Mukai Y; Machinaga A
Nat Commun; 2024 Mar; 15(1):2192. PubMed ID: 38467634
[TBL] [Abstract][Full Text] [Related]
18. A multimodal imaging study to highlight elastin-derived peptide pro-tumoral effect in a pancreatic xenograft model.
Nannan L; Gsell W; Belderbos S; Gallet C; Wouters J; Brassart-Pasco S; Himmelreich U; Brassart B
Br J Cancer; 2023 Jun; 128(11):2000-2012. PubMed ID: 37002342
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies.
Lee JJ; Bernard V; Semaan A; Monberg ME; Huang J; Stephens BM; Lin D; Rajapakshe KI; Weston BR; Bhutani MS; Haymaker CL; Bernatchez C; Taniguchi CM; Maitra A; Guerrero PA
Clin Cancer Res; 2021 Nov; 27(21):5912-5921. PubMed ID: 34426439
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia.
Spadafora V; Pryce BR; Oles A; Talbert EE; Romeo M; Vaena S; Berto S; Ostrowski MC; Wang DJ; Guttridge DC
BMC Cancer; 2024 Apr; 24(1):414. PubMed ID: 38570770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
